- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 62/34 - Unsaturated compounds containing ether groups, groups, groups, or groups
Patent holdings for IPC class C07C 62/34
Total number of patents in this class: 33
10-year publication summary
|
5
|
3
|
3
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4872 |
7 |
| Boehringer Ingelheim International GmbH | 4645 |
3 |
| Les Laboratoires Servier | 538 |
3 |
| Merck & Co., Inc. | 316 |
2 |
| Genentech, Inc. | 3979 |
1 |
| Centre National de La Recherche Scientifique | 10476 |
1 |
| Amgen Inc. | 4093 |
1 |
| F. Hoffmann-la Roche Ltd. | 16 |
1 |
| Eli Lilly and Company | 3861 |
1 |
| Florida Atlantic University Board of Trustees | 95 |
1 |
| Fresenius Medical Care Deutschland GmbH | 2168 |
1 |
| Tallinn University of Technology | 83 |
1 |
| Unigen, Inc. | 111 |
1 |
| Universite Claude Bernard Lyon 1 | 1024 |
1 |
| University of Iowa Research Foundation | 824 |
1 |
| The University of Tokyo | 4201 |
1 |
| Washington University | 1620 |
1 |
| Xenon Pharmaceuticals Inc. | 191 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1346 |
1 |
| Neoleukin Therapeutics, Inc. | 14 |
1 |
| Other owners | 2 |